Telogen Effluvium Clinical Trial
Official title:
Controlled, Randomized, Double Blind Study, for the Evaluation of Tolerance and Trichological Efficacy of a Food Supplement: Bioscalin® New Formulation Versus Reference Formulation Currently on the Market and Placebo
Controlled, randomized, double blind study, for the evaluation of tolerance and trichological efficacy of a food supplement: Bioscalin® new formulation versus reference formulation currently on the market and placebo
Aim of the study was to evaluate clinically and by non-invasive instrumental measurements the
trichological activity of a food supplement taken for 3 months by subjects of both sexes,
aged between 18-60 years, affected by telogen effluvium, with a percentage of hair in anagen
phase < 75%.
In particular the study foresaw the evaluation of the trichological activity of the
Bioscalin® new formulation with Galeopsis Segetum in comparison to a reference product
currently on the market and to placebo.
It was also aim of this study to evaluate treatment tolerance.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04237402 -
Demonstration of the Presence of a Carbonyl Stress in the Hair Follicles of Postpartum Women
|
N/A | |
| Terminated |
NCT02548689 -
PAI-1 Expression in Non-scarring Hair Loss
|
||
| Recruiting |
NCT04834102 -
COVID-19 Induced Telogen Effluvium
|
||
| Not yet recruiting |
NCT04880889 -
BL3000 Compared to Pantogar® in the Treatment of Telogen Effluvium in Women.
|
Phase 3 | |
| Completed |
NCT04652232 -
Efficacy Study of Cosmetic Product Against Telogen Effluvium on Women
|
N/A | |
| Completed |
NCT04450602 -
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
|
N/A | |
| Completed |
NCT04450589 -
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Male Subjects With Hair Loss
|
N/A |